Abingdon Health PLC ABDXF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- $0.07–0.07
- 52-Week Range
- $0.07–0.07
- Bid/Ask
- $0.00 / —
- Market Cap
- $8.52 Mil
- Volume/Avg
- 220,000 / 220,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 84
- Website
- https://www.abingdonhealth.com
Valuation
|
Metric
|
ABDXF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.29 |
Price/Sales | 2.52 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ABDXF
|
|---|---|
Quick Ratio | 1.59 |
Current Ratio | 1.79 |
Interest Coverage | −31.71 |
Quick Ratio
ABDXF
Profitability
|
Metric
|
ABDXF
|
|---|---|
Return on Assets (Normalized) | −31.19% |
Return on Equity (Normalized) | −66.26% |
Return on Invested Capital (Normalized) | −47.04% |
Return on Assets
ABDXF
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Wsdsftrtcg | Vyng | $218.6 Bil | |||
| Danaher Corp
DHR
| Pnbcmfctr | Lkdcqjj | $188.9 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Xgcqthpjd | Tkjkks | $41.8 Bil | |||
| IQVIA Holdings Inc
IQV
| Lzqkfcd | Nlgywn | $39.0 Bil | |||
| Agilent Technologies Inc
A
| Ydltswgtvs | Mrx | $38.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Krhspqtbdh | Wjyrjp | $31.5 Bil | |||
| Icon PLC
ICLR
| Rvsdspwr | Jxgbwmr | $26.3 Bil | |||
| Waters Corp
WAT
| Jlljhdhk | Rymm | $17.5 Bil | |||
| Illumina Inc
ILMN
| Jsmyvkjvm | Qdwppn | $17.4 Bil | |||
| Labcorp Holdings Inc
LH
| Bzgssmlcwj | Bsvdfqp | $16.6 Bil |